Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2011, Pages 240-246

  Luo, Ying ^a,b   Zhang, Bo ^b   Xu, Dun Quan ^b   Liu, Yi ^b   Dong, Ming Qing ^b   Zhao, Peng Tao ^b   Li, Zhi Chao ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Bicyclol; Lipopolysaccharide; NF B

Indexed keywords

BICYCLOL; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; RESPIRATORY TRACT AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MEGADOSE; DRY WEIGHT; ENZYME ACTIVITY; HISTOPATHOLOGY; LUNG EDEMA; LUNG WEIGHT; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SURVIVAL RATE; THERAPY EFFECT; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; BIPHENYL COMPOUNDS; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; PEROXIDASE; PHOSPHORYLATION; TIME FACTORS; TRANSCRIPTION FACTOR RELA;

EID: 79951955753     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.12.005     Document Type: Article

References (33)

1. Repine J.E. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992, 339(8791):466-469.
2. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1334-1349.
3. Wheeler A.P., Bernard G.R. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369(9572):1553-1564.
4. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353(16):1685-1693.
5. Brigham K.L., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986, 133(5):913-927.
6. Ni Y.F., Wang J., Yan X.L., Tian F., Zhao J.B., Wang Y.J., et al. Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respir Res 2010, 11:33.
7. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285(5425):248-251.
8. Kim J.Y., Park J.S., Strassheim D., Douglas I., Diaz D.V.F., Asehnoune K., et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 2005, 288(5):L958-L965.
9. Gong Q., Yin H., Fang M., Xiang Y., Yuan C.L., Zheng G.Y., et al. Heme oxygenase-1 upregulation significantly inhibits TNF-alpha and Hmgb1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol 2008, 8(6):792-798.
10. Liu G.T., Li Y., Wei H.L., Zhang H., Xu J.Y., Yu L.H. Mechanism of protective action of bicyclol against CCl-induced liver injury in mice. Liver Int 2005, 25(4):872-879.
11. Wang H., Li Y. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. Eur J Pharmacol 2006, 534(1-3):194-201.
12. Zhao J., Chen H., Li Y. Protective effect of bicyclol on acute alcohol-induced liver injury in mice. Eur J Pharmacol 2008, 586(1-3):322-331.
13. Yu H.Y., Wang B.L., Zhao J., Yao X.M., Gu Y., Li Y. Protective effect of bicyclol on tetracycline-induced fatty liver in mice. Toxicology 2009, 261(3):112-118.
14. Yao X.M., Chen H., Li Y. Protective effect of bicyclol on liver injury induced by hepatic warm ischemia/reperfusion in rats. Hepatol Res 2009, 39(8):833-842.
15. Zhao D.M., Sun T., Li Y. Yao Xue Xue Bao 2002, 37(6):412-414.
16. Sun L.N., Shen J., Su F., Wang Q., Zhu Y.J., Lou X.E., et al. Bicyclol attenuates oxidative stress and neuronal damage following transient forebrain ischemia in mouse cortex and hippocampus. Neurosci Lett 2009, 459(2):84-87.
17. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149(3 Pt. 1):818-824.
18. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003, 31(4 Suppl.):S195-S199.
19. Chang J.B., Wang Q., Li Y.F. Synthesis and biological activity of Wuweizisu C and analogs. Curr Top Med Chem 2009, 9(17):1660-1675.
20. Liu G.T. Bicyclol: a novel drug for treating chronic viral hepatitis B and C. Med Chem 2009, 5(1):29-43.
21. Liu G.T., Li Y., Wei H.L., Lu H., Zhang H., Gao Y.G., et al. Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study. World J Gastroenterol 2005, 11(5):665-671.
22. Lou X.E., Xu N., Yao H.P., Chen Z. Bicyclol attenuates pro-inflammatory cytokine and chemokine productions in CpG-DNA-stimulated L02 hepatocytes by inhibiting p65-NF-kappaB and p38-MAPK activation. Pharmazie 2010, 65(3):206-212.
23. Bao X.Q., Liu G.T. Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-Induced liver injury through suppression of nuclear factor-kappaB in mice. Mol Pharmacol 2009, 75(5):1180-1188.
24. Meduri G.U., Kohler G., Headley S., Tolley E., Stentz F., Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108(5):1303-1314.
25. Bhatia M., Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004, 202(2):145-156.
26. Chen J., Liu X., Shu Q., Li S., Luo F. Ghrelin attenuates lipopolysaccharide-induced acute lung injury through NO pathway. Med Sci Monit 2008, 14(7):R141-R146.
27. Mei S.H., McCarter S.D., Deng Y., Parker C.H., Liles W.C., Stewart D.J. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007, 4(9):e269.
28. Ueno H., Matsuda T., Hashimoto S., Amaya F., Kitamura Y., Tanaka M., et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004, 170(12):1310-1316.
29. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165(6):2950-2954.
30. Toews G.B. Cytokines and the lung. Eur Respir J Suppl 2001, 34:3s-17s.
31. Goodman R.B., Pugin J., Lee J.S., Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003, 14(6):523-535.
32. Abraham E. NF-kappaB activation. Crit Care Med 2000, 28(4 Suppl):N100-N104.
33. Blackwell T.S., Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997, 17(1):3-9.